Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Jobs & Careers

Founded
2002
Employees
3,000
Total Funding
$3.9B

Founded by Christoph Westphal, David Bartel, John Clarke, Paul Schimmel, Phillip D. Zamore, Phillip Sharp, Robert Langer, Thomas Tuschl in 2002.

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful...

Open Jobs at Alnylam Pharmaceuticals (135)

Discover Alnylam Pharmaceuticals and thousands of other companies hiring around the world on TheJobsMap.